Human Testing for Inovio’s Hep C Vaccine Planned in 2013
Jan 15, 2013
13 Comments
Due to its strong T-cell response in the liver, Inovio’s therapeutic Hepatitis C vaccine will soon be tested in humans.
Continue reading »Hepatitis C Treatments/Therapies
Gilead’s Hep C Regimens Progressing Forward
Jan 9, 2013
5 Comments
As one of the frontrunners in interferon-free Hepatitis C drug development, Gilead provides updates on its Phase II and Phase III studies centering around sofosbuvir and GS-5885.
Continue reading »Treatment for Hepatitis C Genotype 2
Jan 4, 2013
9 Comments
While the standard treatment has not yet changed for Hepatitis C genotype 2, better options are coming soon for this common viral strain.
Continue reading »Interferon-Free Hep C Combos to Watch for in 2013
Jan 2, 2013
72 Comments
For those delaying treatment, we should see progress in 2013 on interferon-free drug regimens for Hepatitis C.
Continue reading »Hemopurifier® to Aid Hep C Therapy in Compassionate-Use Program
Dec 10, 2012
3 Comments
A first-in-class medical device that helps clear Hepatitis C from the blood, the Hemopurifier® will be part of a compassionate-use program for previous Hepatitis C non-responders or relapsers in India.
Continue reading »BIT225 in Phase II Trial for HIV and Hep C Co-Infection
In combination with interferon and ribavirin, Biotron's experimental drug, BIT225, is now being tested in a Phase II trial for those co-infected with Hepatitis C and HIV.
Continue reading »Abbott’s Hep C Drug Trio Cures Most in a Few Months
Nov 15, 2012
9 Comments
In a mid-stage trial, Abbott's all-oral drug combo for Hepatitis C posted cure rates in the 90th percentile - even in previous non-responders.
Continue reading »Simeprevir and VX-135 Team Up in Phase II Hep C Trial
Nov 7, 2012
1 Comment
Vertex's VX-135 is being paired with Medivir and Janssen's simeprevir in an all-oral Phase II Hepatitis C trial.
Continue reading »Novel Hep C Strategy Aimed at Host Cells
Oct 19, 2012
1 Comment
An Israeli company has a drug in development with a unique approach for fighting Hepatitis C - targeting the host cell instead of the virus itself.
Continue reading »99% Cured of Hep C in Abbott’s Interferon-Free Regimen
Oct 19, 2012
30 Comments
Paired with ribavirin, a combination of Abbott's drugs, ABT-450, ABT-267 and ABT-333 eliminated all traces of the Hepatitis C virus in 99 percent of study participants.
Continue reading »
